Codexis (CDXS)

Common Shares
Sell: $2.32|Buy: $2.92|Change: 0.02 (0.87%)

Company profile

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Address

200 Penobscot Drive
Redwood City
CA
USA
94063


Telephone

+1 650 421-8100


Sector 

Healthcare


Previous key dates

NameKey Date
Codexis Inc First Quarter Earnings Conference Call for 20252025-05-02T16:30:00
Codexis Inc First Quarter Earnings Results for 20252025-05-02T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-04T13:10:00
Codexis Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T16:30:00
Codexis Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
Codexis Inc Annual Report for 20242025-02-27T00:00:00
Piper Sandler 36th Annual Healthcare Conference2024-12-03T11:00:00
The Stephens Annual Investment Conference2024-11-21T12:00:00
The Jefferies London Healthcare Conference2024-11-19T09:30:00
15th Annual Craig-Hallum Alpha Select Conference2024-11-19T00:00:00
The Stifel 2024 Healthcare Conference2024-11-18T14:25:00
Codexis Inc Third Quarter Earnings Conference Call for 20242024-10-31T16:30:00
Codexis Inc Third Quarter Earnings Result for 20242024-10-31T00:00:00
The Craig-Hallum Bioprocessing Conference2024-09-19T14:00:00
The Cantor Global Healthcare Conference2024-09-17T11:30:00
Codexis Inc Second Quarter Earnings Conference Call for 20242024-08-08T16:30:00
Codexis Inc Second Quarter Earnings Result for 20242024-08-08T00:00:00
Codexis Inc Annual General Meeting for 20242024-06-11T16:00:00
Codexis Inc Jefferies Global Healthcare Conference 20242024-06-05T11:30:00
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week2024-05-22T16:25:00
Codexis Inc First Quarter Earnings Conference Call for 20242024-05-02T16:30:00
Codexis Inc First Quarter Earnings Result for 20242024-05-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.